CN1484529A - 治疗骨质疏松的骨碎补提取物及其提取方法 - Google Patents
治疗骨质疏松的骨碎补提取物及其提取方法 Download PDFInfo
- Publication number
- CN1484529A CN1484529A CNA008201382A CN00820138A CN1484529A CN 1484529 A CN1484529 A CN 1484529A CN A008201382 A CNA008201382 A CN A008201382A CN 00820138 A CN00820138 A CN 00820138A CN 1484529 A CN1484529 A CN 1484529A
- Authority
- CN
- China
- Prior art keywords
- extract
- alcohol
- preparation
- group
- osteoporosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physical Education & Sports Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Extraction Or Liquid Replacement (AREA)
Abstract
Description
Claims (19)
- 权 利 要 求1. 一种骨碎补的提取物, 其特征在于, 其中总黄酮含量在 30 %以上, 且黄酮中柚皮戒的含量在 30 %以上, 但少于 100 %。
- 2. 根据权利要求 1的提取物, 其特征在于, 其中总黄酮含量 在 50 %以上。
- 3. 根据权利要求 2的提取物, 其特征在于, 其中柚皮甙的含 量在 90 %以下。
- 4. 一种药物组合物, 其特征在于, 其中含有根据权利要求 1 的提取物。
- 5. 根据权利要求 4的药物组合物, 用于治疗骨质疏松。
- 6. 根据权利要求 1的提取物在制备用于治疗骨质疏松药物中 的应用。
- 7. 根据权利要求 1的提取物用于治疗骨质疏松。
- 8. 根据权利要求 1的提取物的制备方法, 其特征在于, 其中 包含以下步骤:1) 用水或醇或其混合物抽提,2) 把提取液用树脂吸附,3) 把吸附了提取物的树脂用水或醇或其混合物洗脱。
- 9. 根据权利要求 8的制备方法, 其特征在于, 用水进行抽提。
- 10. 根据权利要求 8的制备方法, 其特征在于, 用醇 /水混合物 进行抽提。
- 11. 根据权利要求 8或 10的制备方法, 所述醇 /水混合物中, 醇含量为 40 ~ 90 %重量。
- 12. 根据权利要求 8、 10或 11的制备方法, 所述醇选自甲醇和 乙醇。
- 13. 根据权利要求 12的制备方法, 所述醇为乙醇。
- 14. 根据权利要求 13的制备方法, 其特征在于, 所述树脂为大 孔吸附树脂。
- 15. 根据权利要求 8或 14的制备方法, 其特征在于, 所述树脂 吸附了提取液之后, 先用水洗, 然后用醇或醇 /水混合物洗脱。
- 16. 根据权利要求 15的制备方法, 其特征在于, 用醇 /水混合 物进行抽提。
- 17. 根据权利要求 15或 16的制备方法, 所述醇 /水混合物中, 醇含量为 40 ~ 90 %重量。
- 18. 根据权利要求 15、 16或 17的制备方法, 所述醇选自甲醇 和乙醇。
- 19. 根据权利要求 18的制备方法, 所述醇为乙醇。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2000/000739 WO2002053164A1 (fr) | 2000-12-29 | 2000-12-29 | Extraits de drynaria pour le traitement de l'osteoporose et leur procede d'extraction |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1484529A true CN1484529A (zh) | 2004-03-24 |
CN100418521C CN100418521C (zh) | 2008-09-17 |
Family
ID=4574762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB008201382A Expired - Fee Related CN100418521C (zh) | 2000-12-29 | 2000-12-29 | 治疗骨质疏松的骨碎补提取物及其提取方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US7122214B2 (zh) |
JP (1) | JP5093965B2 (zh) |
KR (1) | KR100849253B1 (zh) |
CN (1) | CN100418521C (zh) |
HK (1) | HK1055895A1 (zh) |
WO (1) | WO2002053164A1 (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5508264B2 (ja) | 2007-08-02 | 2014-05-28 | テースリー ファーマシューティカル グループ カンパニー リミテッド | 糖尿病治療のための医薬組成物およびその製造方法 |
CA2825918C (en) | 2011-02-15 | 2018-08-07 | Rotation Medical, Inc. | Methods and apparatus for delivering and positioning sheet-like materials |
CN102229684B (zh) * | 2011-05-11 | 2012-08-01 | 沧州宝恩吸附材料科技有限公司 | 一种分离纯化骨碎补总黄酮专用树脂的合成方法 |
KR101152753B1 (ko) * | 2011-12-30 | 2012-06-18 | 신준식 | 하르파고피툼근 추출물을 유효 성분으로 포함하는 골 대사성 질환의 예방 및 치료용 약학 조성물 |
KR102013457B1 (ko) * | 2012-08-13 | 2019-08-22 | 주식회사 알엔에스 | 에이엠피케이 활성화 효과를 가지는 조성물 |
US9044476B2 (en) | 2013-01-16 | 2015-06-02 | Taipei Medical University | Use of uraria in promoting osteogenesis or providing neuroprotection |
US10258459B2 (en) | 2014-05-09 | 2019-04-16 | Rotation Medical, Inc. | Medical implant delivery system and related methods |
JP2016190814A (ja) * | 2015-03-31 | 2016-11-10 | 株式会社東洋新薬 | カルシウム透過促進剤 |
CN105055462A (zh) * | 2015-08-11 | 2015-11-18 | 张宁 | 一种用于预防和治疗阿尔茨海默病的中药提取物及其应用 |
CN105193869A (zh) * | 2015-10-29 | 2015-12-30 | 北京岐黄制药有限公司 | 骨碎补及其提取物用于预防或治疗心衰的用途 |
CN105147744A (zh) * | 2015-10-29 | 2015-12-16 | 北京岐黄制药有限公司 | 骨碎补及其提取物用于预防或治疗肺心病的用途 |
JP7048025B2 (ja) * | 2017-03-03 | 2022-04-05 | 一正蒲鉾株式会社 | 骨代謝改善用組成物及び骨代謝改善用食品 |
CN108295245A (zh) * | 2018-04-10 | 2018-07-20 | 湖南科技学院 | 增加骨密度药及胶囊剂制备方法 |
CN108854140B (zh) * | 2018-06-01 | 2021-04-02 | 广东展翠食品股份有限公司 | 一种绿色高效萃取佛手黄酮的方法及佛手黄酮 |
CN110646528B (zh) * | 2019-09-16 | 2022-03-01 | 江阴天江药业有限公司 | 一种基于hplc/uplc-qtof-ms检测骨碎补中多成分的方法 |
CN112946111B (zh) * | 2021-01-29 | 2023-01-17 | 广东一方制药有限公司 | 骨碎补生品及其炮制品uplc指纹图谱构建及鉴别方法 |
CN116019847A (zh) * | 2022-12-29 | 2023-04-28 | 西安绿泉科技有限公司 | 一种骨碎补提取物的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1034047C (zh) * | 1992-07-08 | 1997-02-19 | 山东农业大学 | 一种含灭多威的农药组合物 |
CN1116938A (zh) * | 1994-08-18 | 1996-02-21 | 龙勉 | 骨碎补有效成分的提取 |
JP4082823B2 (ja) * | 1999-05-06 | 2008-04-30 | 日本メナード化粧品株式会社 | 光毒性抑制剤 |
-
2000
- 2000-12-29 KR KR1020037008536A patent/KR100849253B1/ko not_active IP Right Cessation
- 2000-12-29 WO PCT/CN2000/000739 patent/WO2002053164A1/zh active Application Filing
- 2000-12-29 US US10/451,966 patent/US7122214B2/en not_active Expired - Fee Related
- 2000-12-29 JP JP2002554113A patent/JP5093965B2/ja not_active Expired - Fee Related
- 2000-12-29 CN CNB008201382A patent/CN100418521C/zh not_active Expired - Fee Related
-
2003
- 2003-11-06 HK HK03108046.4A patent/HK1055895A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN100418521C (zh) | 2008-09-17 |
US20040048811A1 (en) | 2004-03-11 |
JP5093965B2 (ja) | 2012-12-12 |
KR20030072577A (ko) | 2003-09-15 |
US7122214B2 (en) | 2006-10-17 |
KR100849253B1 (ko) | 2008-07-29 |
JP2004521883A (ja) | 2004-07-22 |
WO2002053164A1 (fr) | 2002-07-11 |
HK1055895A1 (en) | 2004-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110455965B (zh) | 药物组合物的制备方法及其hplc指纹图谱建立方法 | |
CN1484529A (zh) | 治疗骨质疏松的骨碎补提取物及其提取方法 | |
CN101244129B (zh) | 拉萨大黄提取物、其制备方法及其在制备治疗心脑血管疾病制剂中的应用 | |
CN102641326B (zh) | 一种黄芪提取物及其制备和应用方法 | |
CN101011527B (zh) | 一种橘红丸的改型制剂及其制备方法 | |
CN102145106A (zh) | 一种治疗骨质疏松症的中药组合物及补肾活血颗粒剂 | |
CN1733273B (zh) | 三金药物制剂的检测方法 | |
CN100415255C (zh) | 一种中药组合物及其制备方法 | |
CN101313971B (zh) | 一种治疗肾病的中药组合物 | |
CN1887324B (zh) | 一种治疗肝肾不足的中药组合物及其制备方法和分析方法 | |
CN100388940C (zh) | 一种小儿高热不退的中药制剂质量控制方法 | |
CN101912594A (zh) | 一种治疗肠胃疾病的中药制剂 | |
CN104257768A (zh) | 各种成分比例稳定均一的大黄总蒽醌及其组合物用于治疗胰腺炎 | |
CN1311812C (zh) | 一种提升白细胞的颗粒剂的制备方法和质量控制方法 | |
CN101879271B (zh) | 橘红胶囊的质量检测方法 | |
CN104224951A (zh) | 各种成分比例稳定均一的大黄总蒽醌及其组合物用于治疗胆囊炎 | |
CN108743795A (zh) | 一种防治糖尿病肾病的朝药提取物及其制备方法和应用 | |
CN100584345C (zh) | 具抗病毒作用的小紫金牛提取物及其提取方法和应用 | |
CN101897942A (zh) | 温脾益肾,泄浊祛瘀的药物组合物的检测方法 | |
CN108553506A (zh) | 葛根总黄酮的制备方法和采用该方法制得的葛兰心宁软胶囊药物 | |
CN102768247A (zh) | 一种治疗冠心病心绞痛药物的检测方法 | |
CN101642492A (zh) | 治疗慢性盆腔炎的药物及其制备方法 | |
CN100434092C (zh) | 含有草木犀成分的组方及其制剂 | |
CN102018740B (zh) | 含有向日葵叶提取物的药物组合物及其用途 | |
CN105616556B (zh) | 一种防治酒精性肝损伤有效组分的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING QIHUANG PHARMACEUTICAL CO., LTD.; APPLICA Free format text: FORMER OWNER: QIHUANG PHARMACEUTICAL INVESTMENT + RESEARCH CO., LTD.; APPLICANT Effective date: 20071221 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20071221 Address after: Room 4, Room 408, building 13, Dongli 4, Bai Jia Zhuang, Chaoyang District, Beijing, China. Zip code: 100026 Applicant after: Beijing Qi Huang Pharmaceutical Co., Ltd. Co-applicant after: Xiyuan Hospital of China Academy of Chinese Medical Sciences Address before: Four floor, 13 East Building, Bai Jia Zhuang, Chaoyang District, Beijing, China. Zip code: 100026 Applicant before: Qi Huang pharmaceutical science and Technology Investment Co., Ltd. Co-applicant before: Xiyuan Hospital of China Academy of Chinese Medical Sciences |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1055895 Country of ref document: HK |
|
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 101200 No. 17 South Street, Pinggu Town, Pinggu District, Beijing, Pinggu Patentee after: Beijing Qihuang pharmaceutical Limited by Share Ltd Patentee after: Xiyuan Hospital of China Academy of Chinese Medical Sciences Address before: Beijing, China Chaoyang District Bai Jia Zhuang East Lane 13, building 4, Room 408 Patentee before: BEIJING QIHUANG PHARMACEUTICAL MANUFACTURING CO., LTD. Patentee before: Xiyuan Hospital of China Academy of Chinese Medical Sciences |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080917 Termination date: 20181229 |
|
CF01 | Termination of patent right due to non-payment of annual fee |